Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.66% |
| 2 | Consumer Discretionary | 8.08% |
| 3 | Energy | 7.71% |
| 4 | Technology | 6.85% |
| 5 | Industrials | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KND
3226
DELISTED
Kindred Healthcare
KND
| $789K | ﹤0.01% |
58,772
-132,417
| -69% | -$1.9M |
|
3227
PUT
RenaissanceRe
RNR
$13.4B
| $788K | ﹤0.01% |
8,700
+1,700
| +24% | +$148K |
|
3228
Booz Allen Hamilton
BAH
$9.32B
| $787K | ﹤0.01% |
+40,744
| New | +$797K |
|
3229
eHealth
EHTH
$39.1M
| $787K | ﹤0.01% |
24,413
-20,183
| -45% | -$556K |
|
|
IRBT
3230
CALL
DELISTED
iRobot
IRBT
| $787K | ﹤0.01% |
20,900
-3,800
| -15% | -$136K |
|
3231
CALL
Carpenter Technology
CRS
$27B
| $784K | ﹤0.01% |
13,500
+7,500
| +125% | +$400K |
|
3232
Fortune Brands Innovations
FBIN
$5.71B
| $784K | ﹤0.01% |
22,042
-242,186
| -92% | -$8.26M |
|
|
IRF
3233
DELISTED
INTL RECTIFIER CORP
IRF
| $782K | ﹤0.01% |
31,584
-46,420
| -60% | -$1.12M |
|
3234
CALL
Pricesmart
PSMT
$5.56B
| $781K | ﹤0.01% |
8,200
-2,300
| -22% | -$207K |
|
|
CAA
3235
CALL
DELISTED
CalAtlantic Group, Inc.
CAA
| $781K | ﹤0.01% |
19,740
+4,680
| +31% | +$185K |
|
3236
CALL
Universal Health Services
UHS
$10B
| $780K | ﹤0.01% |
10,400
-9,200
| -47% | -$642K |
|
3237
PUT
Kirby Corp
KEX
$7.32B
| $779K | ﹤0.01% |
9,000
+600
| +7% | +$50.3K |
|
3238
CALL
Crown Holdings
CCK
$12.9B
| $778K | ﹤0.01% |
18,400
+9,400
| +104% | +$411K |
|
|
PGNX
3239
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $778K | ﹤0.01% |
154,547
-242,707
| -61% | -$1.32M |
|
3240
PUT
CoreCivic
CXW
$3.25B
| $777K | ﹤0.01% |
22,500
+13,800
| +159% | +$462K |
|
3241
CALL
Innoviva
INVA
$1.53B
| $777K | ﹤0.01% |
23,579
-12,658
| -35% | -$394K |
|
|
AMSG
3242
DELISTED
Amsurg Corp
AMSG
| $776K | ﹤0.01% |
19,554
-62,195
| -76% | -$2.42M |
|
3243
CALL
Belden
BDC
$5.31B
| $775K | ﹤0.01% |
12,100
-2,600
| -18% | -$152K |
|
|
CY
3244
CALL
DELISTED
Cypress Semiconductor
CY
| $774K | ﹤0.01% |
82,900
+20,000
| +32% | +$233K |
|
|
DMND
3245
CALL
DELISTED
DIAMOND FOODS, INC.
DMND
| $773K | ﹤0.01% |
32,800
-16,800
| -34% | -$362K |
|
3246
CALL
Arrow Electronics
ARW
$10.9B
| $772K | ﹤0.01% |
15,900
+9,200
| +137% | +$422K |
|
3247
CALL
TE Connectivity
TEL
$62.6B
| $772K | ﹤0.01% |
14,900
+2,600
| +21% | +$130K |
|
|
BRY
3248
CALL
DELISTED
BERRY PETROLEUM CO CL A
BRY
| $772K | ﹤0.01% |
17,900
-33,900
| -65% | -$1.41M |
|
|
OCR
3249
PUT
DELISTED
OMNICARE INC
OCR
| $771K | ﹤0.01% |
13,900
-23,600
| -63% | -$1.26M |
|
3250
CONMED
CNMD
$1.51B
| $770K | ﹤0.01% |
+22,644
| New | +$739K |
|
Similar funds
Ken Griffin's Q3 2013 Portfolio in Review
As of Q3 2013, Ken Griffin held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Ken Griffin's Q3 2013 filing shows 735 new, 2,740 increased, 3,074 reduced and 505 closed positions. Its largest new stake was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M. The largest sale was Pfizer, an estimated $245M.
By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Energy.
- Ken Griffin's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Ken Griffin added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Ken Griffin's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Ken Griffin fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Ken Griffin's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Ken Griffin opened 735 new positions and closed 505 in Q3 2013.
- Ken Griffin's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.